Peter J. Azzarello
Plus aucun poste en cours
Profil
Peter J.
Azzarello worked as Director General at Anaconda Pharma SASU.
He was also Associate Vice President-Financial Reporting at NetBank, Inc. from 2001 to 2003.
From 2004 to 2012, he served as Chief Financial Officer at Inhibitex LLC.
Later, he worked as Secretary, Chief Accounting Officer & VP at Aviragen Therapeutics, Inc. from 2015 to 2016.
Azzarello completed his undergraduate degree from Florida Atlantic University.
Anciens postes connus de Peter J. Azzarello
| Sociétés | Poste | Fin |
|---|---|---|
Aviragen Therapeutics, Inc.
 Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Comptroller/Controller/Auditor | 11/07/2016 |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Director of Finance/CFO | 30/09/2012 |
NetBank, Inc.
 NetBank, Inc. Major BanksFinance NetBank, Inc. provides on-line retail banking and mortgage lending services. It operates in two segments: Retail banking and Mortgage lending. Retail banking provides consumer banking products like checking, money market and certificates of deposit, as well as, online bill payment and presentment, eStatements, wireless account access, account consolidation and securities brokerage services. Mortgage lending provides mortgage loans and related services. The company is headquartered in Alpharetta, GA. | Corporate Officer/Principal | 01/01/2003 |
Anaconda Pharma SASU
 Anaconda Pharma SASU BiotechnologyHealth Technology Anaconda Pharma SAS provides biotechnology services. It offers biotechnology services and develops treatments against infections by human papillomavirus. The company was founded in 2003 and is headquartered in Villejuif, France. | Chief Executive Officer | - |
Formation de Peter J. Azzarello
| Florida Atlantic University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
NetBank, Inc.
NetBank, Inc. Major BanksFinance NetBank, Inc. provides on-line retail banking and mortgage lending services. It operates in two segments: Retail banking and Mortgage lending. Retail banking provides consumer banking products like checking, money market and certificates of deposit, as well as, online bill payment and presentment, eStatements, wireless account access, account consolidation and securities brokerage services. Mortgage lending provides mortgage loans and related services. The company is headquartered in Alpharetta, GA. | Finance |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
Anaconda Pharma SASU
Anaconda Pharma SASU BiotechnologyHealth Technology Anaconda Pharma SAS provides biotechnology services. It offers biotechnology services and develops treatments against infections by human papillomavirus. The company was founded in 2003 and is headquartered in Villejuif, France. | Health Technology |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |
